Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah.
College of Animal Science and Technology, Northwest Agriculture and Forestry University, Yangling, ShanXi, China.
Cancer Res. 2020 Dec 15;80(24):5464-5477. doi: 10.1158/0008-5472.CAN-20-1287. Epub 2020 Oct 28.
Activation of transcription factors is a key driver event in cancer. We and others have recently reported that the Krüppel-like transcription factor KLF5 is activated in multiple epithelial cancer types including squamous cancer and gastrointestinal adenocarcinoma, yet the functional consequences and the underlying mechanisms of this activation remain largely unknown. Here we demonstrate that activation of KLF5 results in strongly selective KLF5 dependency for these cancer types. KLF5 bound lineage-specific regulatory elements and activated gene expression programs essential to cancer cells. HiChIP analysis revealed that multiple distal KLF5 binding events cluster and synergize to activate individual target genes. Immunoprecipitation-mass spectrometry assays showed that KLF5 interacts with other transcription factors such as TP63 and YAP1, as well as the CBP/EP300 acetyltransferase complex. Furthermore, KLF5 guided the CBP/EP300 complex to increase acetylation of H3K27, which in turn enhanced recruitment of the bromodomain protein BRD4 to chromatin. The 3D chromatin architecture aggregated KLF5-dependent BRD4 binding to activate polymerase II elongation at KLF5 target genes, which conferred a transcriptional vulnerability to proteolysis-targeting chimera-induced degradation of BRD4. Our study demonstrates that KLF5 plays an essential role in multiple epithelial cancers by activating cancer-related genes through 3D chromatin loops, providing an evidence-based rationale for targeting the KLF5 pathway. SIGNIFICANCE: An integrative 3D genomics methodology delineates mechanisms underlying the function of KLF5 in multiple epithelial cancers and suggests potential strategies to target cancers with aberrantly activated KLF5.
转录因子的激活是癌症中的一个关键驱动事件。我们和其他人最近报道称,Krüppel 样转录因子 KLF5 在多种上皮癌类型中被激活,包括鳞状细胞癌和胃肠道腺癌,但这种激活的功能后果和潜在机制在很大程度上仍然未知。在这里,我们证明 KLF5 的激活导致这些癌症类型对 KLF5 具有强烈的选择性依赖性。KLF5 结合谱系特异性调节元件,并激活对癌细胞至关重要的基因表达程序。HiChIP 分析显示,多个远端 KLF5 结合事件聚集并协同激活单个靶基因。免疫沉淀-质谱分析表明,KLF5 与其他转录因子如 TP63 和 YAP1 以及 CBP/EP300 乙酰转移酶复合物相互作用。此外,KLF5 指导 CBP/EP300 复合物增加 H3K27 的乙酰化,从而增强溴结构域蛋白 BRD4 到染色质的募集。3D 染色质结构聚集了 KLF5 依赖性 BRD4 结合,以激活 KLF5 靶基因的聚合酶 II 延伸,这为蛋白酶靶向嵌合体诱导的 BRD4 降解赋予了转录脆弱性。我们的研究表明,KLF5 通过激活与癌症相关的基因,在多种上皮癌中发挥重要作用,通过 3D 染色质环提供了针对 KLF5 途径的循证依据。意义:综合 3D 基因组学方法阐明了 KLF5 在多种上皮癌中的功能的潜在机制,并提出了针对异常激活的 KLF5 的癌症的潜在策略。